Medtronic Says FDA Clears InPen App, Clearing Path for Glucose Monitoring System Launch
Medtronic's Smart MDI system, including a continuous glucose monitor and InPen app with missed meal dose detection, is closer to launch as FDA cleared the app. The company plans a limited market release followed by a broad commercial launch.